Xometry, Inc. SEC Filings

Xometry, Inc. (XMTR) insider sale notice filed on Form 144 reports a proposed sale of 1,122 Class A common shares through UBS Financial Services on 10/02/2025, with an aggregate market value of $58,849 and total outstanding shares listed as 49,339,037. The filing states these shares were acquired as a stock award on 10/01/2025 and payment was settled on that date. The filer also disclosed two recent sales by the same person: 598 shares on 09/02/2025 for $30,048.06 and 598 shares on 10/01/2025 for $31,227.50. The form includes the standard signer representation that no undisclosed material adverse information is known.

Xometry, Inc. (XMTR) Form 144 notice reports a proposed sale of 598 shares of Class A Common stock through UBS Financial Services on NASDAQ, with an aggregate market value of $32,196 and an approximate sale date of 10/01/2025. The filer acquired the shares as a stock award on 01/01/2025 from the issuer and indicates payment date as 01/01/2025. The filing also discloses a prior sale of 598 shares on 09/02/2025 that generated gross proceeds of $30,048.06. The form includes the standard signer representation that the seller is not aware of undisclosed material adverse information.

Xometry, Inc. (XMTR) Form 144 notice reports a proposed sale of 4,944 Class A common shares with an aggregate market value of $240,525 to be sold on 09/11/2025 through UBS Financial Services on NASDAQ. The filing lists that the shares were acquired via the issuer under an ESOP on 02/01/2022 and 03/02/2022 and via RSU on 09/15/2025. The filer has disclosed multiple sales in the prior three months: 986, 940, 7,000 and 3,541 shares generating gross proceeds of $30,124.96, $30,444.44, $301,665.00 and $165,915.68 respectively. The filing includes the standard signer representation that no undisclosed material adverse information exists.

Xometry, Inc. (XMTR) insider sale summarized The company's Chief Financial Officer, James Miln, reported selling a total of 598 shares of Class A common stock on 09/02/2025 under a pre-established Rule 10b5-1 trading plan. The sales were executed in multiple transactions with weighted-average prices of $49.7241 and $50.5207, with price ranges disclosed in the filing.

After the reported dispositions the filing shows beneficial ownership levels of 144,508 and 144,115 shares for the two reported lines. The filing states the transactions were automated under the 10b5-1 plan and offers to provide breakdowns of the number of shares sold at each price on request.

Xometry, Inc. (XMTR) filed a Form 144 disclosing a proposed sale of 598 Class A common shares through UBS Financial Services on 09/02/2025. The filing lists an aggregate market value of $29,403.00 and reports 49,339,037 shares outstanding for the class. The shares were acquired as a stock award from the issuer on 01/01/2025, with payment recorded the same day. No other sales in the past three months were reported, and the filer represents they are not aware of undisclosed material adverse information.

Xometry, Inc. (XMTR) Rule 144 notice reports a proposed sale of 3,541 Class A common shares through UBS Financial Services on NASDAQ with an aggregate market value of $169,259. The filer states these shares were acquired by exercising stock options in May and June 2021 for a total of 3,541 shares paid in cash. The filing also discloses prior sales by the same person during the past three months totaling 19,426 shares for gross proceeds of $754,829.40 across four transactions dated June–August 2025. The notice affirms the seller does not possess undisclosed material adverse information.

Brown Capital Management, LLC reports beneficial ownership of 2,943,593 shares of Xometry Inc. Class A common stock, equal to 5.98% of the class. The firm discloses sole dispositive power over all 2,943,593 shares and sole voting power over 1,282,630 shares, and states these shares are held for various investment advisory clients. The filing identifies Brown Capital as an investment adviser and clarifies the holdings are managed in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

This disclosure represents a passive, non-control position by a registered investment adviser and provides clear ownership and voting power figures relevant to shareholders monitoring institutional positions.

Emily Rollins, a director of Xometry, Inc. (XMTR), executed stock-option transactions on 08/11/2025. The filing shows the exercise/conversion of a stock option with an exercise price of $12.32 to acquire 350 shares of Class A common stock, increasing her direct beneficial ownership to 11,455 shares. Table II lists the option details (exercise price $12.32; 350 options; expiration 02/24/2031) and notes the options are fully vested.

The Form 4 was signed by Kristie Scott as attorney-in-fact on 08/12/2025 and filed as a Form 4 reporting transaction code M. No amendments or other transactions are reported in the provided content.

Xometry (XMTR) submitted a Form 144 reporting a proposed sale of 80,770 Class A common shares with an aggregate market value of $3,311,570. The sale is to be executed through UBS Financial Services on NASDAQ with an approximate sale date of 08/08/2025. The filing shows the shares were acquired as RSUs on 01/01/2023 (3,729 shares) and 01/01/2024 (7,041 shares), and 70,000 shares arising from a cashless stock option exercise on 08/08/2025. The form reports no securities sold in the past three months and includes the signatory representation that they know of no undisclosed material adverse information about the issuer.